Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Instil Bio
Biotech
Instil refills pipeline in $2B biobucks deal with ImmuneOnco
The Dallas-based biotech is paying $50 million in upfront and near-term payments—with potentially up to $2 billion to follow in milestones
James Waldron
Aug 1, 2024 10:19am
More layoffs at Instil as cell therapy production shifts to UK
Feb 1, 2023 10:15am
Instil Bio takes the ax to its lead asset, cuts 60% of its staff
Dec 8, 2022 10:24am
